INO Financials
Inovio Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$1.19
Market Cap
$90.57M
EPS
$-1.81
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$217,756
Gross Profit
-
Operating Income
-
Net Income
$-107.25M
EPS (Diluted)
$-3.95
Balance Sheet Highlights
Total Assets
$113.20M
Total Liabilities
$44.69M
Shareholders Equity
-
Cash & Equivalents
$65.81M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-104.08M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-82857.4%
Operating Margin
-1328.7%
ROE
-1.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is INO revenue?
INO's most recent quarterly revenue was $217,756. Annual revenue can be calculated by summing the four most recent quarters.
Is INO profitable?
INO reported a loss of $107.25M in the most recent quarter.
What is INO market cap?
INO has a market capitalization of $90.57M, making it a small-cap stock.
Does INO have debt?
View INO's balance sheet for debt information.
What is INO cash flow?
Cash flow data is available in the full financial statements.